Electrochemical DNA Detection of Hepatitis E Virus Genotype 3 Using PbS Quantum Dot Labelling

Overview

Journal Anal Bioanal Chem

Specialty Chemistry

Date 2020 Nov 25

PMID 33236225

Citations 4

Authors

Duy Ba Ngo

Thanyarat Chaibun

Lee Su Yin

Benchaporn Lertanantawong

Werasak Surareungchai

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to develop a highly specific electrochemical DNA sensor using functionalized lead sulphide (PbS) quantum dots for hepatitis E virus genotype 3 (HEV3) DNA target detection. Functionalized-PbS quantum dots (QDs) were used as an electrochemical label for the detection of HEV3-DNA target by the technique of square wave anodic stripping voltammetry (SWASV). The functionalized-PbS quantum dots were characterized by UV-vis, FTIR, XRD, TEM and zeta potential techniques. As-prepared, functionalized-PbS quantum dots have an average size of 4.15 ± 1.35 nm. The detection platform exhibited LOD and LOQ values of 1.23 fM and 2.11 fM, respectively. HEV3-DNA target spiked serum is also reported.Graphical abstract.

Citing Articles

Theranostics: a multifaceted approach utilizing nano-biomaterials.

Yasir M, Mishra R, Tripathi A, Maurya R, Shahi A, Zaki M Discov Nano. 2024; 19(1):35.

PMID: 38407670 PMC: 10897124. DOI: 10.1186/s11671-024-03979-w.

Biosensors for waterborne virus detection: Challenges and strategies.

Song X, Fredj Z, Zheng Y, Zhang H, Rong G, Bian S J Pharm Anal. 2024; 13(11):1252-1268.

PMID: 38174120 PMC: 10759259. DOI: 10.1016/j.jpha.2023.08.020.

Label-free ultra-sensitive colorimetric detection of hepatitis E virus based on oxidase-like activity of MnO nanosheets.

Alam N, Ravikumar C, Sreeramareddygari M, Somasundrum M, Surareungchai W Anal Bioanal Chem. 2022; 415(4):703-713.

PMID: 36469053 PMC: 9734815. DOI: 10.1007/s00216-022-04461-1.

Application of Nanomaterials as an Advanced Strategy for the Diagnosis, Prevention, and Treatment of Viral Diseases.

Lim J, Ahn Y, Park G, Kim H, Haam S Pharmaceutics. 2021; 13(10).

PMID: 34683863 PMC: 8540357. DOI: 10.3390/pharmaceutics13101570.

References

Perez-Gracia M, Suay B, Mateos-Lindemann M . Hepatitis E: an emerging disease. Infect Genet Evol. 2014; 22:40-59. DOI: 10.1016/j.meegid.2014.01.002. View

van der Poel W . Food and environmental routes of Hepatitis E virus transmission. Curr Opin Virol. 2014; 4:91-6. DOI: 10.1016/j.coviro.2014.01.006. View

Albinana-Gimenez N, Clemente-Casares P, Bofill-Mas S, Hundesa A, Ribas F, Girones R . Distribution of human polyomaviruses, adenoviruses, and hepatitis E virus in the environment and in a drinking-water treatment plant. Environ Sci Technol. 2006; 40(23):7416-22. DOI: 10.1021/es060343i. View

Hewitt J, Harte D, Sutherland M, Croucher D, Fouche L, Flanagan P . Prevalence of hepatitis E virus antibodies and infection in New Zealand blood donors. N Z Med J. 2018; 131(1469):38-43. View

Kenney S, Meng X . Hepatitis E Virus: Animal Models and Zoonosis. Annu Rev Anim Biosci. 2018; 7:427-448. DOI: 10.1146/annurev-animal-020518-115117. View

Meng X . Zoonotic and foodborne transmission of hepatitis E virus. Semin Liver Dis. 2013; 33(1):41-9. DOI: 10.1055/s-0033-1338113. View

Kamar N, Dalton H, Abravanel F, Izopet J . Hepatitis E virus infection. Clin Microbiol Rev. 2014; 27(1):116-38. PMC: 3910910. DOI: 10.1128/CMR.00057-13. View

Purcell R, Emerson S . Hidden danger: the raw facts about hepatitis E virus. J Infect Dis. 2010; 202(6):819-21. PMC: 2941993. DOI: 10.1086/655900. View

Zhu F, Zhang J, Zhang X, Zhou C, Wang Z, Huang S . Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010; 376(9744):895-902. DOI: 10.1016/S0140-6736(10)61030-6. View

10.

Cao Y, Bing Z, Guan S, Zhang Z, Wang X . Development of new hepatitis E vaccines. Hum Vaccin Immunother. 2018; 14(9):2254-2262. PMC: 6183316. DOI: 10.1080/21645515.2018.1469591. View

11.

Nan Y, Wu C, Zhao Q, Sun Y, Zhang Y, Zhou E . Vaccine Development against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges. Front Microbiol. 2018; 9:266. PMC: 5827553. DOI: 10.3389/fmicb.2018.00266. View

12.

Shalimar , Acharya S . Hepatitis e and acute liver failure in pregnancy. J Clin Exp Hepatol. 2015; 3(3):213-24. PMC: 3940148. DOI: 10.1016/j.jceh.2013.08.009. View

13.

Bernal W, Wendon J . Acute liver failure. N Engl J Med. 2013; 369(26):2525-34. DOI: 10.1056/NEJMra1208937. View

14.

Komolmit P, Oranrap V, Suksawatamnuay S, Thanapirom K, Sriphoosanaphan S, Srisoonthorn N . Clinical significance of post-liver transplant hepatitis E seropositivity in high prevalence area of hepatitis E genotype 3: a prospective study. Sci Rep. 2020; 10(1):7352. PMC: 7192897. DOI: 10.1038/s41598-020-64551-x. View

15.

Aggarwal R . Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol. 2012; 10(1):24-33. DOI: 10.1038/nrgastro.2012.187. View

16.

Inoue J, Takahashi M, Yazaki Y, Tsuda F, Okamoto H . Development and validation of an improved RT-PCR assay with nested universal primers for detection of hepatitis E virus strains with significant sequence divergence. J Virol Methods. 2006; 137(2):325-33. DOI: 10.1016/j.jviromet.2006.07.004. View

17.

Menon P, Kapila K, Ohri V . POLYMERASE CHAIN REACTION AND ADVANCES IN INFECTIOUS DISEASE DIAGNOSIS. Med J Armed Forces India. 2017; 55(3):229-231. PMC: 5531883. DOI: 10.1016/S0377-1237(17)30450-1. View

18.

Fredricks D, Relman D . Application of polymerase chain reaction to the diagnosis of infectious diseases. Clin Infect Dis. 1999; 29(3):475-86; quiz 487-8. DOI: 10.1086/598618. View

19.

Yang S, Rothman R . PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis. 2004; 4(6):337-48. PMC: 7106425. DOI: 10.1016/S1473-3099(04)01044-8. View

20.

Wei F, Lillehoj P, Ho C . DNA diagnostics: nanotechnology-enhanced electrochemical detection of nucleic acids. Pediatr Res. 2010; 67(5):458-68. PMC: 2876983. DOI: 10.1203/PDR.0b013e3181d361c3. View